ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2009;8:206-210. doi:10.1510/icvts.2008.187666
© 2009 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Toshihiko Shibata
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, T.
Right arrow Articles by Mizoguchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, T.
Right arrow Articles by Mizoguchi, H.

Institutional report - Valves

Which valve and which size should we use in the valve-on-valve technique for re-do mitral valve surgery?

Toshihiko Shibataa,*, Kazushige Inoueb, Takeshi Ikutab, Yasuyuki Bitob, Yoshiteru Yoshiokab and Hiroki Mizoguchib

a Department of Cardiovascular Surgery, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima, Osaka, 534-0021, Japan
b Department of Cardiovascular Surgery, Kansai Rosai Hospital, Amagasaki, Japan

Received 7 July 2008; received in revised form 18 October 2008; accepted 23 October 2008

*Corresponding author. Tel.: +81-6-6929-1221; fax: +81-6-6929-1090.

E-mail address: shibata-cvs{at}zeus.eonet.ne.jp (T. Shibata).


    Abstract
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
The valve-on-valve (VOV) technique is that a mechanical valve is implanted on the sewing cuff of the previous bioprosthesis after removing degenerated leaflets. We conducted an in vitro study to determine the size-match of the valves for VOV technique. The Carpentier–Edwards pericardial (CEP) valve and Mosaic valve were used. We measured the inner diameter of the bioprosthesis after removing the leaflets. We investigated five mechanical mitral valves and two mechanical aortic valves (inverted use). The mitral valves used in this study were the ATS valve (ATS), the CarboMedics standard valve (CMS), the CarboMedics OptiForm valve (CMO), the On-X valve, and the St Jude valve (SJM). Two aortic mechanical valves, CarboMedics and St Jude Regent valves, were investigated for inverted use. After removing the tissue leaflets, the inner diameter of the Mosaic valve was 3 mm smaller than that of the CEP valve even in the same catalogue labeling size. The outer diameters of the housing of the ATS, CMS, CMO, On-X, and SJM valves of the same catalogue size (25 mm) were 25.7, 25.8, 22.0, 25.0, and 23.2 mm, respectively. SJM and CMO valves are the favorite mechanical valve for the VOV technique in terms of the profile and size-match.

Key Words: Valve-on-valve; Mitral valve replacement; Re-do; Bioprosthesis


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
Although current bioprosthetic models have significantly better durability than previous models, structural failure is inevitable in the long-term [1, 2]. Structural degeneration of bioprostheses occurs more frequently in the mitral position than in the aortic position. Re-do mitral valve surgery has high mortality and morbidity [3, 4].

Paterson et al. [5] and Stassano et al. [6] reported a new technique of re-do mitral valve surgery without explantation of the initially implanted bioprosthesis. They implanted a new mechanical valve on the sewing cuff of the previously implanted bioprosthesis after removing the degenerated leaflets. The advantage of this alternative technique is that there is no need to remove the initially implanted bioprosthesis. In addition, the aortic cross-clamping time is shorter. The disadvantage of this technique is that the newly implanted mechanical valve is smaller than the initially implanted bioprosthesis.

Several reports about the valve-on-valve (VOV) technique have described the use of a mechanical bileaflet valve 6–8 mm smaller in diameter than the bioprosthetic valve [5–7]. A recent report by Geha et al. demonstrated that a bileaflet mechanical valve (St Jude valve or CarboMedics valve) with an external diameter only 2 mm smaller than that of the mitral bioprosthesis could be implanted [8]. As shown in Table 1 [5–15], there is a limited amount of information about the VOV technique, and no reports demonstrate systematically which valve and which size are available for the VOV technique. Therefore, we conducted an in vitro study to determine the optimal size-match between the mechanical valves and bioprosthetic valves for applying the VOV technique.


View this table:
[in this window]
[in a new window]

 
Table 1 Valve size in previous reports of the valve-on-valve technique

 

    2. Material and methods
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
We employed two kinds of bioprostheses; the Carpentier–Edwards PERIMOUNT pericardial valve (CEP model 6900, Edwards Lifesciences, Irvine, LA) and the Medtronic Mosaic porcine valve (Medtronic, Minneapolis, MN). We chose a pericardial valve and a porcine valve that are widely used throughout the world. The CEP (model 6900) was introduced into clinical use. The Mosaic valve is a current model of the porcine valve, however, the housing and structures of the sewing ring are the same as the previous model (Hancock II). We used two catalogue labeling sizes (27 mm and 29 mm) in each bioprosthetic valve. All leaflets of the bioprostheses were excised with a No.11 blade. We investigated five mechanical mitral valves and two mechanical aortic valves. The mechanical mitral valves that we used were the ATS standard valve (ATS) (ATS Medical, Minneapolis, MN), the CarboMedics standard valve (CMS), the CarboMedics OptiForm valve (CMO) (SulzerMedica, Austin, TX), the On-X valve (Medical Carbon Research Institute, Austin, TX), and the St Jude Master valve (SJM) (St Jude Medical, St Paul, MN). The aortic valves used in this study were CarboMedics (CMA-S) (Sulzer Medica) and St Jude Regent valves (Regent) (St Jude Medical, St Paul, MN).

2.1. Profile of the mechanical valves and definition of the housing

The portion of the mechanical valve to be inserted into the sewing ring of the bioprosthetic valve depends on the individual design of the mechanical valve. According to the profile of the mechanical valve, we defined two types of housing to be inserted in the bioprosthesis. First, there was a carbon housing consisting of a frame made by pyrolitic carbon containing the leaflets. Secondly, there was a fabric housing consisting of fabric around the carbon housing. The schema of the profile of each mechanical valve is shown in Fig. 1. The carbon housing of the ATS and CMS valves was almost completely covered with the fabric. On the On-X valve, there was no fabric around the carbon housing to be inserted in the bioprosthetic valve. The carbon housing partially protruded from the sewing cuff and there was a fabric dip of the sewing cuff around the carbon housing on the SJM and CMO valves. From a technical view of the VOV technique, there is impingement of the leaflet if the carbon housing of the SJM, CMO, and On-X valves are completely seated inside the sewing ring of the bioprosthesis. The fabric housing of the ATS and CMS valves must be inserted in the bioprosthesis. According to the design of the mechanical valves as mentioned above, we measured only the fabric housing diameter on the ATS and CMS valves, and only the outer diameter of the carbon housing on the SJM, CMO, and On-X valves.


Figure 1
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 1. Schema of the profile of the mitral mechanical valves and inverted use of aortic mechanical valves. ATS, ATS standard valve; CMS, CarboMedics standard valve; CMO, CarboMedics OptiForm valve; SJM, St Jude Medical Master valve; CM-aortic, CarboMedics aortic valve; Regent, St Jude Medical Regent valve; C, carbon housing; F, fabric housing.

 
We measured the inner diameter (ID) of the orifice of the bioprosthesis after removing the leaflets using an electronic vernier caliper that can be measured to an accuracy of 0.01 mm. The mean diameter, which was measured by five different authors (TS, YM, YB, TI, and KI) individually, was used in this study. The outer diameters of the carbon housing and the fabric housing were measured in the same manner. We mounted each mechanical valve on the bioprosthesis after removing all the leaflets. We checked if each mechanical valve was completely seated inside the sewing ring of the bioprosthesis without disorder of the leaflet opening.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
3.1. Inner diameters of the sewing ring of the bioprosthesis

Fig. 2 shows the bioprosthetic valves after removing the tissue leaflet of the bioprosthesis. In the CEP valve, there is a remnant of the tissue leaflet on the stent, but no tissue leaflet remained surrounding the inner orifice of the sewing cuff. In the Mosaic valve, the remnant of the tissue leaflet surrounding the inner orifice of the sewing cuff could not be removed completely. The inner diameters of the bioprosthesis after removal of the tissue leaflet are shown in Table 2. The inner diameter of the Mosaic valve was approximately 3 mm smaller than that of the CEP valve, even though they had the same catalogue labeling size.


Figure 2
View larger version (56K):
[in this window]
[in a new window]

 
Fig. 2. Bioprosthetic valves after removing the tissue leaflet. Carpentier–Edwards pericardial valve (a), Mosaic valve (b).

 

View this table:
[in this window]
[in a new window]

 
Table 2 Inner diameters of bioprostheses

 
3.2. Outer diameter of the mechanical valves

The OD of the carbon housing or fabric housing, which was measured by five authors, is shown in Table 3. The results of actual availability of the mechanical valves for the VOV technique are also shown in Table 3. If the OD of the housing is smaller than the ID of the bioprosthetic sewing ring, theoretically, the mechanical valve can be inserted. However, the mechanical valve could actually be inserted in the bioprosthetic valve only when the OD of the housing of the mechanical valve was about 0.5 mm smaller than the ID of the sewing ring of the bioprosthetic valve.


View this table:
[in this window]
[in a new window]

 
Table 3 Comparison of mitral mechanical valves and bioprosthetic valves for the valve-on-valve technique

 
Inverted use of the CMS-A 25 mm and the Regent 21 mm can be used for the VOV technique on the Mosaic 27 mm valve. The sewing cuff of the aortic mechanical valve is narrower than that of the mitral mechanical valve, and some aortic valves are too small to apply the VOV technique.


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
The actual size of the housing and sewing ring is quite different among the individual artificial valves, even if they have the same catalogue labeling size. We need to recognize the individual characteristics of the designs and actual size of both bioprosthetic and mechanical valves. This in-vitro study described a guide for choosing mechanical valves when we apply the VOV technique to re-do mitral valve surgery.

4.1. Bioprosthetic valves

This study revealed that the actual size of the Mosaic valve is smaller than the CEP valve even with the same catalogue labeling size. The catalogue labeling size is derived from the diameter of inter-stent (diameter of wire-form) in the CEP valve, but from the outer diameter of the stent post in the Mosaic valve (Fig. 3). Therefore, the real size of the CEP valve is essentially different from that of the Mosaic valve even with the same labeling size. The manufacturing technique of mounting the tissue leaflets on the sewing ring and the stent is quite different between the CEP and Mosaic valves. The tissue leaflets of the CEP valve are attached to the stent alone, while the tissue leaflets of the Mosaic valve are sewn on both the inner orifice of the sewing ring and the stent (Fig. 2). This difference in the manufacturing process affected the inner orifice size of the bioprosthetic valves after removing the tissue leaflet. The tissue orifice of the sewing cuff of the Mosaic valve is 2 mm smaller than that of the CEP in the catalogue. After removing the leaflet, the internal orifice of the housing in the Mosaic valve is 3 mm smaller than that of the CEP valve, because the tissue leaflet of the Mosaic valve could not be removed completely on the structural aspect as mentioned above.


Figure 3
View larger version (7K):
[in this window]
[in a new window]

 
Fig. 3. The definition of catalogue labeling size of bioprosthetic valves. L, the diameter of the defined catalogue labeling size. Carpentier–Edwards pericardial valve (left), Mosaic valve (right).

 
4.2. Size of the housing

The location for the mechanical valve to be inserted in the sewing ring of the bioprosthetic valves depends on the individual design of the mechanical valve (Fig. 1). Therefore, we first defined the two types of housing of mechanical valves, the carbon housing and the fabric housing, according to the design of the housing, and then measured each part of the housing to be inserted. Needless to say, the OD of the housing of the mechanical valve must be smaller than the ID of the sewing ring of the bioprosthetic valve for applying the VOV technique. The mechanical valve can be theoretically mounted on the bioprosthetic valve if the OD of the mechanical valve housing is smaller than the ID of the sewing ring of the bioprosthetic valve. In actual surgery, however, it is very difficult to mount the mechanical valve in the center of the sewing ring of the bioprosthetic valve. Therefore, a difference between the OD of the housing of the mechanical valve and the ID of the sewing ring of the bioprosthetic valve would be required. We think that a clearance of more than 1 mm would be required between the two parameters in the clinical situation.

4.3. Mechanical valves

The SJM and CMO valves are implantable if the carbon housing can be inserted inside the sewing ring of the bioprosthetic ring. This characteristic of the design is an advantage in terms of size compared to other mechanical valves. The only two mechanical mitral valves that can be mounted on the Mosaic 27 mm valve are the SJM 23 mm and CMO 25 mm valves (Table 3). From a technical point of view, the St Jude valves are preferred, owing to the fact that the leaflets are hinged on the atrial side and do not protrude into the ventricular side. This design of SJM valves would avoid impingement of the disks on the bioprosthetic valve.

The carbon housing of the ATS and CMS valves are completely surrounded by the fabric. Therefore, the fabric housing must be inserted completely in the sewing ring of the bioprosthetic valve. This means that the size of the ATS and CMS valves must be one size smaller than the SJM and CMO valves. ATS and CMS valves have a disadvantage in terms of size; however, if the fabric housing is completely inserted in the sewing ring of the bioprosthetic valve, there is no impingement of the bileaflet disks. We believe that the ATS and CMS valves can be used only when the large size of CEP has been used in the previous operation.

The On-X valve has a unique design, and the carbon housing protrudes to the left ventricular side. The bileaflet disks can open and close if the carbon housing is completely seated in the sewing ring of the bioprosthetic valve.

4.4. Limitations of this study

The major limitation of this study is that it was conducted in vitro study. We investigated brand new bioprosthetic valves in this study. In the clinical situation, it would be more difficult to remove the tissue leaflet completely in vivo than in vitro. Moreover, the sewing cuff would be surrounded by pseudo-intima after initial implantation. The sewing cuff itself might have some time-dependent degeneration. Therefore, the ID of the sewing ring of the bioprosthetic ring at actual re-do surgery might be smaller than our in vitro data. We believe that our in vitro data could be helpful in the decision making process for the VOV technique.


    5. Conclusions
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 
SJM and CMO valves are the favorite mechanical valve for the VOV technique in terms of the profile and size-match.


    References
 Top
 Abstract
 1. Introduction
 2. Material and methods
 3. Results
 4. Discussion
 5. Conclusions
 References
 

  1. Riess FC, Bader R, Cramer E, Hansen L, Kleijnen B, Wahl G, Wallrath J, Winkel S, Bleese N. Hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years. Ann Thorac Surg 2007;83:1310–1318.[Abstract/Free Full Text]
  2. Marchand MA, Aupart MR, Norton R, Goldsmith IR, Pelletier LC, Pellerin M, Dubiel T, Daenen WJ, Herijgers P, Casselman FP, Holden MP, David TE. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001;71:S236–S239.[CrossRef][Medline]
  3. Akins CW, Buckley MJ, Daggett WM, Hilgenberg AD, Vlahakes GJ, Torchiana DF, Madsen JC. Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg 1998;65:1545–1551.[Abstract/Free Full Text]
  4. Piehler JM, Blackstone EH, Bailey KR, Sullivan ME, Pluth JR, Weiss NS, Brookmeyer RS, Chandler JG. Reoperation on prosthetic heart valves. Patient-specific estimates of in-hospital events. J Thorac Cardiovasc Surg 1995;109:30–48.[Abstract/Free Full Text]
  5. Stassano P, Losi MA, Golino A, Gagliardi C, Iorio D, Marzullo M, Spampinato N. Bioprosthesis replacement with mechanical valve implantation on the bioprosthetic ring. Eur J Cardiothorac Surg 1993;7:507–510.[Abstract]
  6. Paterson HS, Jacob A, Campanella C, Bloomfield P, Cameron EWJ. Retention of bioprosthetic valve annulus in mitral prosthetic replacement. Eur J Cardiothorac Surg 1993;7:511–513.[Abstract]
  7. Gega AS, Lee JH. Evolution of the surgical approach for replacement of degenerated mitral bioprostheses. Surgery 1995;118:662–668.[CrossRef][Medline]
  8. Geha AS, Massad MG, Snow NJ. Replacement of degenerated mitral and aortic bioprostheses without explantation. Ann Thorac Surg 2001;72:1509–1514.[Abstract/Free Full Text]
  9. Geha AS, Lee JH. New approach for replacement of degenerated mitral bioprostheses. Eur J Cardiothorac Surg 1996;10:1090–1096.[Abstract]
  10. Stassano P, Musumeci A, Losi MA, Gagliardi C, Spampinato N. Mid-term results of the valve-on-valve technique for bioprosthetic failure. Eur J Cardiothorac Surg 2000;18:453–457.[Abstract/Free Full Text]
  11. Sakakibara Y, Moriki N, Doi T, Unno H, Matsuzaki K, Mitsui T. Implantation of a mechanical valve within the orifice of a mitral bioprosthesis in a case with severely calcified left atrium. Angiology 1998;49:857–860.[CrossRef][Medline]
  12. Tamura Y, Kawata T, Kameda Y, Taniguchi S. Re-do mitral valve replacement using the valve-on-valve technique: a case report. Ann Thorac Cardiovasc Surg 2005;11:125–127.[Medline]
  13. Tateishi M, Koide M, Kunii Y, Watanabe K, Ohsawa M. Valve-in-valve replacement of primary tissue valve failure of bovine pericardial valve (in Japanese with English abstract). Kyobu Geka 2006;59:61–64.[Medline]
  14. Furukawa T, Komiya T, Tamura N, Sakaguchi G, Kimura C, Kobayashi T, Nakamura H, Matsushita A. Replacement of a degenerated mitral bioprosthesis using a valve-on-valve technique (in Japanese with English abstract). Jpn J Cardiovasc Surg 2007;36:58–62.[Medline]
  15. Midorikawa H, Satou K, Ogawa T, Hoshino S. Valve-on-valve technique for replacement of degenerated tricuspid bioprosthetic valve without explantation. Jpn J Thorac Cardiovasc Surg 2006;54:81–84.[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Toshihiko Shibata
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, T.
Right arrow Articles by Mizoguchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, T.
Right arrow Articles by Mizoguchi, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS